All posts

OrganiGram is a cheap pot stock, says Beacon Securities

Beacon Securities analyst Russell Stanley says that not only is cannabis name OrganiGram Holdings (OrganiGram Holdings Stock Quote, Chart TSXV:OGI) currently trading at a substantial discount to its broader peer group, on a technical basis the stock is now trading at levels that should offer strong support.

On Tuesday, Moncton, New Brunswick-based OrganiGram announced that it had entered into an exclusive agreement allowing it to license Feather Company’s proprietary vaporizer pen technology and form factor, with management contending that the technology targets the more sophisticated cannabis consumer.

In an update to clients Tuesday, Stanley said OGI is well-positioned as a partner of choice for the agreement, as it is one of a select few companies with sales relationships in all ten Canadian provinces. The analyst also says that once Cannabis 2.0 comes into effect this fall, he expects vape products to be a major sales driver across Canada, as they represent greater than 20 per cent of sales in US states with rec and/or medical legalization.

“OGI is now trading at 12x our C2020E EBITDA estimate (which is a weighted average of our F2020 and F2021 estimates, given OGI’s August 31 FYE). This represents a 49 per cent discount to the 23x average for the broad peer group, and a 61 per cent discount to the 30x average amongst companies that trade on either NASDAQ or NYSE,” said Stanley.

The analyst says that upcoming potential catalysts for OGI include the company’s third quarter results in July, continued expansion updates and additional news on product development. Stanley is maintaining his “Buy” rating and $15.00 target price for OGI, which represents a projected return of 80 per cent at the time of publication.

Stanley thinks OrganiGram will generate fiscal 2019 revenue and adjusted EBITDA of $107.1 million and $54.3 million, respectively, and fiscal 2020 revenue and adjusted EBITDA of $218.8 million and $111.2 million, respectively.

More Cantech Cannabis

Tagged with: ogi
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Verano Holdings is undervalued, Haywood says

Haywood Capital Markets analyst Neal Gilmer says Verano Holdings (Verano Holdings Stock Quote, Chart, News, Analysts, Financials NEO:VRNO) is staying… [Read More]

12 hours ago

Knight Therapeutics is a buy, Stifel says

Knight Therapeutics (Knight Therapeutics Stock Quote, Chart, News, Analysts, Financials TSXV:GUD) is continuing to build momentum, according to Stifel Nicolaus… [Read More]

13 hours ago

Groupon wins price target raise at Roth

Roth Capital Partners has raised its price target on Groupon (Groupon Inc Stock Quote, Chart, News, Analysts, Financials NASDAQ:GRPN) to… [Read More]

14 hours ago

Trulieve Cannabis is a buy, Beacon says

Trulieve Cannabis (Trulieve Cannabis Stock Quote, Chart, News, Analysts, Financials CSE:TRUL) delivered a strong start to fiscal 2025, beating high-end… [Read More]

16 hours ago

Green Thumb Industries should be a core holding for cannabis investors, analyst says

Green Thumb Industries (Green Thumb Industries Stock Quote, Chart, News, Analysts, Financials CSE:GTII) delivered a steady first quarter and remains… [Read More]

17 hours ago

5N Plus just delivered an “exceptional” quarter, this analyst says

5N Plus (5N Plus Stock Quote, Chart, News, Analysts, Financials TSX:VNP) blew past expectations in the first quarter of 2025,… [Read More]

1 day ago